Even though the mean SNAQ score was increased and the ghrelin levels were decreased following iron therapy, the SNAQ score remained significantly lower in the IDA group when compared to the control group, suggesting that IDA patients remain at higher risk for malnutrition compared to healthy control population (Table 5). The gene discussed is GHRL; the disease is nutritional deficiency disease.